Hologic, Inc., a global leader in women’s health, today released its 2025 Sustainability Report. The new report coincides ...
Hologic announced today that it picked up a victory over Siemens Healthineers in the Unified Patent Court (UPC) in Germany.
FDA warns of a breast biopsy needle shortage through March 2027 due to a Hologic recall. Learn how this affects patient care ...
With the removal of hemodialysis bloodlines, the FDA's medical device shortage list now totals six product codes.
The Unified Patent Court in Germany has ruled that Siemens Healthineers infringed on Hologic's mammography technology patent.
The Food and Drug Administration said that the US is experiencing a shortage of breast biopsy needles after Hologic Inc. recalled the products earlier this year, potentially causing delays in ...
Unified Patent Court (UPC) in Germany, which ruled that Siemens* infringed upon a critical Hologic mammography technology patent in Siemens' latest mammography system. The court imposed a sweeping ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced an innovative new partnership with the American Association of Gynecologic ...
Hologic’s HOLX Molecular Diagnostics business posted a 7.8% (excluding COVID-19-related sales) growth in the second quarter of fiscal 2025, although results did not reflect its full potential.The ...
An ongoing shortage of breast biopsy needles is expected to continue through March 2027, the Food and Drug Administration ...
Report outlines actions helping to reduce environmental impact, advance health equity and engage a purpose-driven workforce Hologic, Inc., a global leader in women's health, today released its 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results